Marshall Wace LLP Invests $192,000 in Protalix BioTherapeutics, Inc. (NYSE:PLX)
Marshall Wace LLP bought a new stake in Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 101,899 shares of the company’s stock, valued at approximately $192,000. Marshall Wace LLP owned approximately 0.14% of Protalix BioTherapeutics as […]
Marshall Wace LLP bought a new stake in Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 101,899 shares of the company’s stock, valued at approximately $192,000. Marshall Wace LLP owned approximately 0.14% of Protalix BioTherapeutics as […]
